DIRS.INFO The most relevant business & tech news

☆ Top NFL Week 2 storylines: Bengals-Chiefs next chapter; C.J. Stroud, Caleb Williams on SNF
▼ + stars: | 2024-09-15 | by ( Mike Jones | ) www.nytimes.com time to read: +11 min

The 16 teams that lost last week look to bounce back with performances that reflect improvement and promise. Rodgers completed 13 of 21 passes for 167 yards, a touchdown and an interception, and the Jets managed just 68 rushing yards. Stroud, the best quarterback from last year’s draft class, and Chicago’s Caleb Williams, the first pick of this year’s draft. Stroud continued to impress in Week 1, throwing for 234 yards, two touchdowns and no interceptions. After the game, Williams vowed, “I will be better.” Excelling against a talented Texans defense, however, could prove challenging.

Persons: what’s, Tua Tagovailoa, Aaron Rodgers, Rodgers, Will Levis, Malik Willis, Jordan Love, Green, Matt LaFleur, Willis, LaFleur, Love, Patrick Mahomes, Denny Medley, NFL schedulers, Joe Burrow, Mahomes, Burrow, Burrow's, Ja’Marr Chase, Tee Higgins, Higgins, Macdonald, Jerod Mayo, Bill Belichick, Mike Macdonald, Geno Smith, Jacoby Brissett, Smith, Baker Mayfield, Nathan Ray Seebeck, He’ll, Aidan Hutchinson, Jared Goff, Goff, Mayfield, Mike Evans, Derrick Barnes, Williams, Houston’s, Chicago’s Caleb Williams, Stroud, CJ Stroud, He’s, Jonathan Owens, Tyrique Stevenson, Williams didn’t, “, Kevin C, Cox Organizations: NFL, Buffalo, Bills, Dolphins, Falcons – Eagles, Cowboys, Bears, Texans, Jets, Tennessee Titans, Tennessee, Chicago Bears, Ravens, Packers, Bengals, Jaguars, Browns, Rams, Titans, 49ers, Eagles, Detroit Lions, NFC, Liberty University, Green, Indianapolis Colts, Lambeau, Colts, Chiefs, Sunday, AFC, Baltimore, Mayo, Patriots, Mayo’s Patriots, Macdonald’s Seahawks, Broncos, The Patriots, Seahawks, Bucs, Lions NFC, Lions, Buccaneers, Washington, Tampa, Stroud, AFC South, Indianapolis, Chicago Locations: Miami, Philadelphia, San Francisco, Brazil, Green, Mahomes, New England, Seattle, Baltimore, Mayo, Foxboro, USA, Tampa ., Detroit, Houston’s C.J, Stroud

☆ A rare voice box transplant helped a cancer patient speak again, part of a pioneering study
▼ + stars: | 2024-07-09 | by ( Associated Press | ) edition.cnn.com time to read: +7 min

Transplants of the so-called voice box are extremely rare, and normally aren’t an option for people with active cancer. “People need to keep their voice,” Kedian, 59, told The Associated Press four months after his transplant – still hoarse but able to keep up an hourlong conversation. Dr. Michael Hinni, center left, Dr. Payam Entezami, center, and Dr. David Lott, center right, operate on transplant patient Marty Kedian in Phoenix in February. But Belafsky said there’s “still a shot” for larynx transplants to become more common while cautioning it likely will take years more research. Mayo Clinic via APKedian was diagnosed with a rare laryngeal cartilage cancer about a decade ago.

Persons: Marty Kedian, –, ” Kedian, “, ”, David Lott, Mayo’s, Michael Hinni, Payam, haven’t, ” Lott, Mayo, Marshall Strome, Peter Belafsky, UC Davis, Belafsky, there’s “, Girish Mour, AP Kedian, wouldn’t, Gina, Lott, Dr, Sanjay Gupta, Kedian, he’d, Charlotte Organizations: Washington AP, U.S, Surgeons, Mayo Clinic, Associated Press, Cleveland Clinic, University of California, American Cancer Society, UC, AP, Mayo, CNN, CNN Health Locations: Massachusetts, Arizona, Phoenix, Mayo, U.S, Davis, Cleveland, Haverhill , Massachusetts, Boston

Overall, an FDA spokesperson says that “trial participants should reflect the population that is likely to use the product if FDA-approved. Across a group of 10 novel cancer therapies approved by the FDA in 2022, data shows the share of Black participants in key clinical trials ranged from zero to 8%. “Access to clinical trials at the sites where patients are living is an important factor to changing the landscape,” Perez says. “There’s been some novel ways to recruit patients, like using the church and using barbershops to recruit Black patients,” Cho says. Haddad says a number of Mayo patients were receiving experimental therapies through clinical trials when the pandemic began.

Persons: ”, Leslie Cho, Robert, Suzanne Tomsich, it’s, Edith Perez, Bolt Biotherapeutics, ” Perez, Eli Lilly, “, Lilly “, they’ll, Craig Lipset, ” Lipset, ” Cho, “ There’s, Dr, Tufia Haddad, Haddad, Mayo, Jennifer Dahne, Larry Hawk, Hawk Organizations: Women’s Cardiovascular, Cleveland Clinic, of Cardiovascular Medicine, U.S . Food, Drug Administration, FDA, “, Health, Committee, Cancer, Janssen Pharmaceuticals, Centers for Disease Control, Research Alliance, Mayo Clinic Comprehensive Cancer Center, Care, Mayo’s Center for Digital Health, College of Medicine, Medical University of South, of Psychology, University, Buffalo, SUNY, JAMA Locations: U.S, Chicago, Dallas, Los Angeles, Philadelphia, Los Angeles County, Alaska, “, Medical University of South Carolina

☆ New Alzheimer’s drug shows promise in slowing disease but may contain significant risks, study shows
▼ + stars: | 2022-11-30 | by ( The Associated Press | ) www.nbcnews.com time to read: +5 min

An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday — but it remains unclear how much difference that might make in people’s lives. Now the companies are providing full results of the study of nearly 1,800 people in the earliest stages of the mind-robbing disease. Also, lecanemab recipients were 31% less likely to advance to the next stage of the disease during the study. The trial is important because it shows a drug that attacks a sticky protein called amyloid — considered one of several culprits behind Alzheimer’s — can delay disease progression, said Maria Carrillo, chief science officer for the Alzheimer’s Association. Eisai said Tuesday the deaths can’t be attributed to the Alzheimer’s drug.

Search resuls for: "Mayo’s"

4 mentions found